Global Drug Delivery Devices Market, By Route of Administration (Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal), End-User (Hospitals, Clinics, Home Care Settings), Distribution Channel (Direct Tenders,Hospital Pharmacies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Trends and Forecast To 2024
Global Drug Delivery Devices Market has accounted for USD 1,027.0 billion in 2016 and is expected to reach USD 1,914.9 billion by 2024 at a CAGR of 8.1% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The market is segmented on the basis of route of administration, end-user, distribution channel and geography.
On the basis of route of administration the market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal.
The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs.
The liquid drugs are further classified into solutions and syrups.
Browse Full Report with List of Tables and Figures at databridgemarketresearch.com/repor…y-devices-market/
Based on end users the market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others. The hospitals segment dominate the global drug delivery devices market with more than 50.0% market share, however by volume the hospitals segment holds approximately 45.0% of the market.
On the basis of distribution channel the drug delivery devices market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy. In 2016, the direct tenders segment is expected to dominate the market.
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East Africa. The geographical regions are further segmented into 24 major countries such as U.S.
Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
The global drug delivery market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. Some examples of recent strategies adopted by market players are: April 2017,Novartis received FDA approval for Rydapt for two indications.
The first indication is for the treatment of acute myeloid leukemia (AML) in newly diagnosed patients and second for the treatment of adults with advanced systemic mastocytosis (SM). This approval will follow a prior Breakthrough Therapy designation in FLT3-mutated AML along with Orphan Drug designation and Priority Review in both indications by the FDA.
Some of the major players operating in this market are
- Bayer AG
- Johnson & Johnson
- Novartis AG
- Pfizer, Inc.
- F. Hoffmann-La RocheAG
- GlaxoSmithKline plc.
- Merck & Co.
- Antares Pharma
- Becton Dickinson and Company
- Cima Labs, Inc.
- Dali Medical Devices
- Skyepharma AG
- Valeant Pharmaceuticals
- DSM Biomedical
- Catalent, Inc.
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: